Clinical Trials Directory

Trials / Completed

CompletedNCT03246594

Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Heart Center Leipzig - University Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The Trial will evaluate the influence of oesophageal probes in Radio frequency (RF)-ablation of atrial fibrillation regarding oesophageal ulcers after ablation.

Detailed description

The Trial will evaluate the influence of oesophageal probes in RF-ablation of atrial fibrillation regarding oesophageal complications after ablation. 200 patients will be prospectively randomised into 2 groups. The conventional group will undergo RF-Ablation of atrial fibrillation using an oesophageal probe to measure the temperature during ablation. In the other group will receive ablation using fixed energy levels (25 Watt) at the posterior left atrial (LA) Wall without an oesophageal probe , All patients will get a gastroscopy for evaluation of oesophageal complications the day after the procedure. All patients will have a 6 months follow up (FU) in our clinic to be reevaluated for complications (primary endpoint) and rhythm stability. (secondary endpoint)

Conditions

Interventions

TypeNameDescription
DEVICEPlacement of oesophageal probe for temperature measurementThe oesophagus probe is used to measure the intraluminal temperature inside the oesophagus
DEVICEPower limitation of RF generatorno probe utilized; Limit the RF Generator Output to 25W

Timeline

Start date
2017-07-03
Primary completion
2019-04-25
Completion
2019-10-24
First posted
2017-08-11
Last updated
2020-05-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03246594. Inclusion in this directory is not an endorsement.